Skip to Main Content

Paper Details

Subgroup analysis of clinical and MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study.
Mult Scler Relat Disord
6
2021
CDMS, CUA, FCDE, Gd, Gd+, MS, Patient, T1, T1 Gd, T2, T2 lesions, cladribine, clinical demyelinating event, demyelinating event, gadolinium, multiple sclerosis, participants
Author NameAffiliation
Bruce A C CreeUCSF Weill Institute for Neurosciences
James D BowenSwedish Neuroscience Institute
Hans-Peter HartungUniversity Hospital of Dusseldorf, Heinrich-Heine-Universitat
Fernando DangondEMD Serono Research & Development Institute, Inc.
  • 1 - 4

Datasets

Release 1.2